Free Newsletter
Jury rules for Pfizer in Prempro case
A Wyeth menopause drug did not cause a woman's breast cancer, and the drugmaker is not liable for damages, a Philadelphia jury found yesterday--two days after another local jury found against parent company Pfizer and levied nearly $10 million in damages. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: